Early-phase human studies (including data in healthy older adults) have been conducted, but robust clinical evidence supporting its use in confirmed GH deficiency or any other licensed indication is lacking
Legal Status and Testing Concerns GHRP-6, like many growth hormone secretagogues, exists in a regulatory gray zone
Other factors, such as side effects, dosing schedules, and the type of model being studied, can also affect the decision
By mimicking natural cell membranes, liposomes fuse with intestinal and cellular membranes, allowing glutathione to enter cells directly and bypass digestive breakdown
Other mild effects while adapting to treatment are headaches, nausea, or fatigue